WDR81
Basic information
Region (hg38): 17:1716523-1738599
Links
Phenotypes
GenCC
Source:
- cerebellar ataxia, intellectual disability, and dysequilibrium syndrome 2 (Limited), mode of inheritance: AR
- cerebellar ataxia, intellectual disability, and dysequilibrium syndrome 2 (Strong), mode of inheritance: AR
- cerebellar ataxia, intellectual disability, and dysequilibrium (Supportive), mode of inheritance: AR
- cerebellar ataxia, intellectual disability, and dysequilibrium syndrome 2 (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Cerebellar ataxia, impaired intellectual development, and dysquilibrium syndrome 2; Hydrocephalus, nonsyndromic, autosomal recessive 3 | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Neurologic | 16371500; 21885617; 25558065; 26437881; 28556411 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (6 variants)
- Cerebellar ataxia, intellectual disability, and dysequilibrium syndrome 2 (3 variants)
- Inborn genetic diseases (2 variants)
- Microlissencephaly (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the WDR81 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 90 | 20 | 113 | |||
missense | 209 | 15 | 228 | |||
nonsense | 12 | |||||
start loss | 0 | |||||
frameshift | 8 | |||||
inframe indel | 1 | |||||
splice donor/acceptor (+/-2bp) | 1 | |||||
splice region | 1 | 2 | 7 | 1 | 11 | |
non coding | 9 | |||||
Total | 9 | 14 | 217 | 108 | 24 |
Highest pathogenic variant AF is 0.0000328
Variants in WDR81
This is a list of pathogenic ClinVar variants found in the WDR81 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
17-1716626-C-T | Likely benign (Aug 01, 2024) | |||
17-1724976-G-C | Inborn genetic diseases | Uncertain significance (May 20, 2024) | ||
17-1724990-G-A | Inborn genetic diseases | Uncertain significance (Jul 19, 2023) | ||
17-1725010-G-A | Likely benign (Jun 01, 2023) | |||
17-1725027-C-A | Inborn genetic diseases | Uncertain significance (Oct 10, 2023) | ||
17-1725037-C-G | Inborn genetic diseases | Uncertain significance (Mar 27, 2023) | ||
17-1725080-G-C | Inborn genetic diseases | Uncertain significance (Mar 30, 2024) | ||
17-1725084-C-T | Inborn genetic diseases | Uncertain significance (Dec 01, 2022) | ||
17-1725100-G-C | Likely benign (May 20, 2018) | |||
17-1725110-G-A | Inborn genetic diseases | Uncertain significance (Apr 18, 2023) | ||
17-1725165-G-T | Inborn genetic diseases | Uncertain significance (Jul 09, 2021) | ||
17-1725168-G-A | Inborn genetic diseases | Uncertain significance (Nov 09, 2023) | ||
17-1725176-CT-C | Pathogenic (Feb 09, 2022) | |||
17-1725204-T-C | Inborn genetic diseases | Uncertain significance (Jun 06, 2023) | ||
17-1725229-C-T | Benign (Dec 31, 2019) | |||
17-1725254-C-T | Inborn genetic diseases | Uncertain significance (Jul 30, 2023) | ||
17-1725287-C-T | Likely benign (Aug 28, 2017) | |||
17-1725291-G-C | Inborn genetic diseases | Uncertain significance (Nov 15, 2023) | ||
17-1725296-C-T | Inborn genetic diseases | Uncertain significance (Sep 23, 2023) | ||
17-1725300-G-C | Inborn genetic diseases | Uncertain significance (Nov 17, 2022) | ||
17-1725340-C-A | Inborn genetic diseases | Likely benign (May 01, 2024) | ||
17-1725341-G-C | Inborn genetic diseases | Uncertain significance (Feb 27, 2024) | ||
17-1725418-T-A | Inborn genetic diseases | Uncertain significance (Mar 02, 2023) | ||
17-1725435-G-A | Inborn genetic diseases | Uncertain significance (Jun 06, 2023) | ||
17-1725441-C-T | Cerebellar ataxia, intellectual disability, and dysequilibrium syndrome 2 | Uncertain significance (Jan 01, 2019) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
WDR81 | protein_coding | protein_coding | ENST00000409644 | 10 | 22077 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
6.75e-8 | 1.00 | 125557 | 0 | 47 | 125604 | 0.000187 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.11 | 1000 | 1.21e+3 | 0.829 | 0.0000799 | 12394 |
Missense in Polyphen | 391 | 528.73 | 0.7395 | 5658 | ||
Synonymous | 1.60 | 502 | 550 | 0.913 | 0.0000389 | 4227 |
Loss of Function | 4.57 | 24 | 63.2 | 0.380 | 0.00000336 | 664 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000723 | 0.000709 |
Ashkenazi Jewish | 0.000102 | 0.0000993 |
East Asian | 0.000164 | 0.000163 |
Finnish | 0.000504 | 0.000462 |
European (Non-Finnish) | 0.000162 | 0.000159 |
Middle Eastern | 0.000164 | 0.000163 |
South Asian | 0.0000657 | 0.0000653 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Functions as a negative regulator of the PI3 kinase/PI3K activity associated with endosomal membranes via BECN1, a core subunit of the PI3K complex. By modifying the phosphatidylinositol 3-phosphate/PtdInsP3 content of endosomal membranes may regulate endosome fusion, recycling, sorting and early to late endosome transport (PubMed:26783301). It is for instance, required for the delivery of cargos like BST2/tetherin from early to late endosome and thereby participates indirectly to their degradation by the lysosome (PubMed:27126989). May also play a role in aggrephagy, the macroautophagic degradation of ubiquitinated protein aggregates. In this process, may regulate the interaction of SQSTM1 with ubiquitinated proteins and also recruit MAP1LC3C (PubMed:28404643). May also be involved in maintenance of normal mitochondrial structure and organization (By similarity). {ECO:0000250|UniProtKB:Q5ND34, ECO:0000269|PubMed:26783301, ECO:0000269|PubMed:27126989, ECO:0000269|PubMed:28404643}.;
Intolerance Scores
- loftool
- 0.504
- rvis_EVS
- -1.76
- rvis_percentile_EVS
- 2.34
Haploinsufficiency Scores
- pHI
- 0.266
- hipred
- Y
- hipred_score
- 0.563
- ghis
- 0.523
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.985
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | High |
Cancer | High | Medium | High |
Mouse Genome Informatics
- Gene name
- Wdr81
- Phenotype
- nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); vision/eye phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); cellular phenotype; growth/size/body region phenotype;
Gene ontology
- Biological process
- ubiquitin-dependent protein catabolic process;mitochondrion organization;negative regulation of phosphatase activity;aggrephagy;regulation of phosphatidylinositol 3-kinase activity;early endosome to late endosome transport;protein stabilization
- Cellular component
- autophagosome membrane;mitochondrion;lysosomal membrane;endoplasmic reticulum membrane;Golgi apparatus;cytosol;extrinsic component of endosome membrane;early endosome membrane;late endosome membrane
- Molecular function
- protein binding;phosphatidylinositol 3-kinase regulator activity;K63-linked polyubiquitin modification-dependent protein binding